Lucid Diagnostics
Natalie Carfora serves as the Vice President of Market Access & Reimbursement at Lucid Diagnostics since August 2023, following a role as Head of Market Access at Immunovia, Inc. from May 2022 to August 2023. Prior experience includes positions at Scipher Medicine as Director of Market Access and at Myriad Genetics, where Natalie held various roles including Regional Account Manager for Payer Markets and Clinical Liaison for the Autoimmune Division, achieving multiple national rankings and awards for performance. Earlier career experiences feature sales roles at Mentor Worldwide, LLC, and Eli Lilly and Company, complemented by a foundation in marketing from Conde Nast. Natalie earned a Bachelor of Science in Business Administration with concentrations in Finance and Marketing from the Questrom School of Business at Boston University.
This person is not in any teams
Lucid Diagnostics
1 followers
Lucid Diagnostics Inc. is a subsidiary of PAVmed Inc (Nasdaq: PAVM) that has breakthrough devices, EsoCheck and EsoGuard, for esophageal cell collection and diagnosis of Barrett's Esophagus.